Caris Life Sciences, Inc.
Status: Publicly traded
Direct answer
Caris Life Sciences, Inc. is publicly traded on NASDAQ under the ticker CAI.
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of...
Can you invest in Caris Life Sciences, Inc.?
Yes. Caris Life Sciences, Inc. trades publicly on NASDAQ as CAI.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Caris Life Sciences, Inc.
Detailed equity research is provided by MarketSnap.